Anupam Rasayan India Limited has informed the Exchange about Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday, relating to the mandatory open offer by our Company to the public shareholders of Bliss GVS Pharma Limited
ANURAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anupam Rasayan India Limited has filed a Draft Letter of Offer with SEBI through its Manager to the Offer, initiating a mandatory open offer for the public shareholders of Bliss GVS Pharma Limited. This filing is a regulatory step required before launching the open offer to acquire shares from minority shareholders of Bliss GVS Pharma. The move follows an underlying acquisition transaction that triggers the SEBI Takeover Regulations requirement for a mandatory open offer. Specific offer price, size, and timeline details will be disclosed in the final letter of offer once SEBI clears the draft.
This confirms Anupam Rasayan is moving ahead with its acquisition of a stake in Bliss GVS Pharma, giving public shareholders of Bliss GVS a chance to tender shares at the offer price. For Anupam Rasayan shareholders, it signals expansion via acquisition, though the financial impact will depend on the final offer price and deal size.